Commonwealth Equity Services LLC Has $2.18 Million Holdings in Haleon plc (NYSE:HLN)

Commonwealth Equity Services LLC lowered its position in shares of Haleon plc (NYSE:HLN) by 1.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 256,730 shares of the company’s stock after selling 4,655 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Haleon were worth $2,180,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in HLN. Hexagon Capital Partners LLC raised its holdings in shares of Haleon by 107.3% during the fourth quarter. Hexagon Capital Partners LLC now owns 4,236 shares of the company’s stock valued at $35,000 after acquiring an additional 2,193 shares during the period. Pinnacle Bancorp Inc. raised its holdings in shares of Haleon by 853.4% during the fourth quarter. Pinnacle Bancorp Inc. now owns 4,767 shares of the company’s stock valued at $39,000 after acquiring an additional 4,267 shares during the period. Allspring Global Investments Holdings LLC acquired a new stake in shares of Haleon during the first quarter valued at approximately $43,000. Tower Research Capital LLC TRC raised its holdings in shares of Haleon by 146.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 5,398 shares of the company’s stock valued at $44,000 after acquiring an additional 3,211 shares during the period. Finally, SRS Capital Advisors Inc. raised its holdings in shares of Haleon by 456.4% during the fourth quarter. SRS Capital Advisors Inc. now owns 5,458 shares of the company’s stock valued at $45,000 after acquiring an additional 4,477 shares during the period. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Stock Down 0.1 %

Haleon stock traded down $0.01 during trading hours on Friday, hitting $8.45. The company had a trading volume of 1,511,640 shares, compared to its average volume of 5,308,539. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.04 and a quick ratio of 0.73. The firm has a market capitalization of $38.58 billion, a P/E ratio of 28.17, a price-to-earnings-growth ratio of 2.25 and a beta of 0.24. Haleon plc has a fifty-two week low of $7.70 and a fifty-two week high of $8.96. The firm’s fifty day moving average is $8.41 and its 200-day moving average is $8.35.

Haleon (NYSE:HLN) last posted its earnings results on Wednesday, May 1st. The company reported $0.12 EPS for the quarter, topping the consensus estimate of $0.11 by $0.01. The company had revenue of $3.70 billion during the quarter, compared to the consensus estimate of $3.71 billion. Haleon had a net margin of 9.68% and a return on equity of 13.17%. On average, research analysts forecast that Haleon plc will post 0.46 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have weighed in on HLN. Berenberg Bank began coverage on shares of Haleon in a research note on Wednesday, June 5th. They issued a “buy” rating on the stock. Argus reiterated a “buy” rating on shares of Haleon in a research note on Tuesday, March 26th. Finally, HSBC began coverage on shares of Haleon in a research note on Wednesday, April 17th. They issued a “buy” rating on the stock. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, Haleon presently has a consensus rating of “Moderate Buy”.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.